CORDIS · 945253 · H2020
APAL Advanced PTS Analysis for LTO
Coordinator: UJV REZ AS (CZ)
In the EU, most of the nuclear power plants (NPPs) are currently in the second half of their designed lifetime, making lifetime extension an important aspect for the EU countries. One of the most limiting safety assessments for long term operation (LTO) is the reactor pressure vessel (RPV) integrity assessment for pressurized thermal shock (PTS). The goal is to demonstrate the safety margin against fast fracture initiation or RPV failure. To verify safe operation of existing NPPs going through LTO upgrades, advanced methods and improvements are necessary.In the EU, currently used PTS analyses…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
EU contribution: €4.0M awarded to the consortium. The project runs over approximately 4 years from 2020-10-01 to 2024-09-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from CZ
see all →- ESPOSA — Efficient Systems and Propulsion for Small Aircraft284859 · FP7 · €25.0M
- IMPULSE — Integrated Management and reliable oPerations for User-based Laser Scientific Excellence871161 · H2020 · €20.0M
- RICAIP — Research and Innovation Centre on Advanced Industrial Production857306 · H2020 · €15.0M
- FATRESCON — Concrete matrices for high-cycle-fatigue resistant, eco-efficient infrastructure101167045 · HORIZON · €10.0M
- CLOSER — Party Systems and Social Cleavages in the Post-Ottoman Space of the MENA Region101224232 · HORIZON · €9.8M
- 3Stops2Go — THREE STOP CODONS TO GET OVER TO FLOURISH101224040 · HORIZON · €9.8M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the RIA funding scheme.
- What is the EU contribution?
- The European Commission contributes €4.0M.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call NFRP-2019-2020.
- Who coordinates the project?
- The project is coordinated by UJV REZ AS (CZ).
- What is the project timeline?
- The project runs from 2020-10-01 to 2024-09-30 — approximately 4 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 945253.